Sol Atriyal Apendiks Kapama Cihaz Embolizasyonu

Reddy VY, Doshi SK, Kar S, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial. Circulation. 2013.

Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy. J Am Coll Cardiol. 2014.

Lakkireddy D, Thaler D, Ellis CR, et al. Amplatzer Amulet Left Atrial Appendage Occluder versus Watchman Device for Stroke Prophylaxis (Amulet IDE): a randomized, controlled trial. Circulation. 2021.

Aminian A, Lalmand J, Tzikas A, Budts W, Benit E, Kefer J. Embolization of left atrial appendage closure devices: A systematic review of cases reported with the watchman device and the amplatzer cardiac plug. Catheter Cardiovasc Interv. 2015 Jul;86(1):128-35. doi: 10.1002/ccd.25891. Epub 2015 Feb 25. Erratum in: Catheter Cardiovasc Interv. 2016 Jun;87(7):1362. doi: 10.1002/ccd.26589.

Boersma LVA, Schmidt B, Betts TR, et al. Left Atrial Appendage Occlusion versus Direct Oral Anticoagulants in Atrial Fibrillation: Rationale and Design of the LAAO-DE Trial. European Heart Journal, 2021.

Mansour MJ, Bénic C, Didier R, Noel A, Gilard M, Mansourati J. Late discovery of left atrial appendage occluder device embolization: a case report. BMC Cardiovasc Disord. 2020 Jun 22;20(1):305. doi: 10.1186/s12872-020-01589-9.